From Name:
From Email:
To Name:
To Email:

Optional Message:

Prostate Cancer: No Survival Hit With Surveillance

from MedPage Today

Men with early prostate cancer lived just as long with active surveillance as with upfront treatment, even though they had a significantly higher risk of developing metastatic disease, a randomized trial showed. After 10 years of follow-up, 169 of 1,643 men in the study had died, resulting in death rates of 10.1 to 10.9 per 1,000 person-years across three treatment groups – active surveillance, radiation therapy, or radical prostatectomy. Men in all three groups had a miniscule likelihood of dying of prostate cancer, as a total of 17 prostate cancer deaths occurred in 10 years. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063